Sandra St Louis Thompson
Family · Lenoir, NCNPI 1013525310
Payments from drug & device makers
Across 32 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$190
- Lilly USA, LLC$75
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$47
- Exact Sciences$46
- AbbVie$43
- Novo Nordisk$37
- plus $146 from 8 others
What the payments were for
- Food & beverage$53692%
- Education$478%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $190 |
| Lilly USA, LLC | 4 | $75 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $47 |
| Exact Sciences | 3 | $46 |
| AbbVie | 2 | $43 |
| Novo Nordisk | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Organon | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Pfizer | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Cequr Corporation | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Alkermes, Inc. | 1 | $12 |
How this compares
$583 in reported general payments places this provider in the 60th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KerendiaFinerenone | 12 | $13,424 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $533 |
| Buspirone Hcl | 19 | $419 |
| Fluticasone Propionate | 31 | $418 |
| Omeprazole | 22 | $324 |
| Doxycycline Hyclate | 32 | $252 |
| Atorvastatin Calcium | 31 | $178 |
| Losartan Potassium | 16 | $175 |
| FenofibrateFenofibrate Nanocrystallized | 13 | $151 |
| Levothyroxine Sodium | 29 | $113 |
| Rosuvastatin Calcium | 16 | $110 |
| Metformin Hcl | 13 | $95 |
| Methylprednisolone | 13 | $93 |
| Amlodipine Besylate | 27 | $90 |
| Sertraline Hcl | 16 | $74 |
Paid to pharmacies, not to this prescriber.
Other family in Lenoir
- Teri LeeLenoir$40K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.